PepGen Non Current Liabilities Other from 2010 to 2024

PEPG Stock  USD 4.48  0.07  1.59%   
PepGen's Non Current Liabilities Other is decreasing over the last several years with slightly volatile swings. Non Current Liabilities Other is predicted to flatten to about 15.2 M. During the period from 2010 to 2024 PepGen Non Current Liabilities Other regressed destribution of quarterly values had coefficient of variationof  5.72 and r-value of (0.57). View All Fundamentals
 
Non Current Liabilities Other  
First Reported
2010-12-31
Previous Quarter
17.1 M
Current Value
15.2 M
Quarterly Volatility
1.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PepGen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PepGen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 4.1 M or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.42. PepGen financial statements analysis is a perfect complement when working with PepGen Valuation or Volatility modules.
  
Check out the analysis of PepGen Correlation against competitors.
For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.

Currently Active Assets on Macroaxis

When determining whether PepGen is a strong investment it is important to analyze PepGen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PepGen's future performance. For an informed investment choice regarding PepGen Stock, refer to the following important reports:
Check out the analysis of PepGen Correlation against competitors.
For more detail on how to invest in PepGen Stock please use our How to Invest in PepGen guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PepGen. If investors know PepGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PepGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.98)
Return On Assets
(0.35)
Return On Equity
(0.66)
The market value of PepGen is measured differently than its book value, which is the value of PepGen that is recorded on the company's balance sheet. Investors also form their own opinion of PepGen's value that differs from its market value or its book value, called intrinsic value, which is PepGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PepGen's market value can be influenced by many factors that don't directly affect PepGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PepGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if PepGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PepGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.